A detailed history of Franklin Resources Inc transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Franklin Resources Inc holds 1,763,277 shares of SNDX stock, worth $23.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,763,277
Previous 1,763,277 -0.0%
Holding current value
$23.1 Million
Previous $33.9 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$17.93 - $24.81 $3.73 Million - $5.16 Million
208,043 Added 13.38%
1,763,277 $33.9 Million
Q2 2024

Aug 14, 2024

BUY
$18.82 - $23.79 $1.12 Million - $1.42 Million
59,529 Added 3.98%
1,555,234 $31.9 Million
Q1 2024

May 13, 2024

BUY
$19.71 - $24.57 $2.81 Million - $3.51 Million
142,800 Added 10.56%
1,495,705 $35.6 Million
Q4 2023

Feb 09, 2024

BUY
$11.39 - $21.67 $15.4 Million - $29.3 Million
1,352,905 New
1,352,905 $29.2 Million

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.